Cargando…

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling

Leucine-rich glioma inactivated 1 (Lgi1), a putative tumor suppressor, is tightly associated with autosomal dominant lateral temporal lobe epilepsy (ADLTE). It has been shown that Lgi1 regulates the myelination of Schwann cells in the peripheral nervous system (PNS). However, the function and underl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Ya-Jun, Zhou, Lin, Wang, Yin, Jiang, Nan-Wei, Cao, Shenglong, Shao, Chong-Yu, Wang, Xin-Tai, Li, Xiang-Yao, Shen, Ying, Zhou, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043672/ https://www.ncbi.nlm.nih.gov/pubmed/30034322 http://dx.doi.org/10.3389/fnmol.2018.00231

Ejemplares similares

Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum
por: Xie, Ya-Jun, et al.
Publicado: (2015)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere
por: Rachdi, Amine, et al.
Publicado: (2019)

The TSC-mTOR pathway regulates macrophage polarization
por: Byles, Vanessa, et al.
Publicado: (2013)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
por: Messelmani, Mariem, et al.
Publicado: (2015)

CMTM6 knockdown prevents glioma progression by inactivating the mTOR pathway
por: Wei, Li, et al.
Publicado: (2022)

Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
por: Murayama, Aki, et al.
Publicado: (2022)

Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
por: Kwon, Nyoun Soo, et al.
Publicado: (2017)

Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia
por: Yuan, Xiaoling, et al.
Publicado: (2020)

Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice
por: Chabrol, Elodie, et al.
Publicado: (2010)

Leucine-rich glioma-inactivated protein 1 antibody encephalitis: A case report
por: Mayasi, Yunis, et al.
Publicado: (2014)

Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023)

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
por: Presneau, N, et al.
Publicado: (2009)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer
por: Mrozek, Evelyn M., et al.
Publicado: (2021)

Methylation of Hypothalamic Tsc1-mTOR Signaling in Regulation of Obesity and Obesity Resistance
por: Wang, Yanli, et al.
Publicado: (2020)

mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
por: Manzoni, Claudia, et al.
Publicado: (2016)

Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?
por: Habib, Samy L, et al.
Publicado: (2016)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
por: Lin, You-ting, et al.
Publicado: (2019)

Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis
por: Takkar, Aastha, et al.
Publicado: (2016)

Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
por: Hou, Lan, et al.
Publicado: (2022)

Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures
por: Li, Zhimei, et al.
Publicado: (2016)

Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated
por: Cabrera-López, Cristina, et al.
Publicado: (2015)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor
por: Dhamne, Sameer C., et al.
Publicado: (2023)

Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
por: Lin, Nan, et al.
Publicado: (2020)

Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway
por: Gao, Shangfeng, et al.
Publicado: (2017)

Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients
por: Farag, Azza Gaber Antar, et al.
Publicado: (2019)

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Binks, Sophie N. M., et al.
Publicado: (2021)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
por: Karvigh, Sanaz Ahmadi, et al.
Publicado: (2022)

Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors
por: Carson, Robert P., et al.
Publicado: (2015)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
por: Li, Jinyi, et al.
Publicado: (2023)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
por: Wang, Sheng-jun, et al.
Publicado: (2020)

miR-301a Suppression within Fibroblasts Limits the Progression of Fibrosis through the TSC1/mTOR Pathway
por: Wang, Jiexuan, et al.
Publicado: (2020)

Corrigendum: Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
por: Lin, Nan, et al.
Publicado: (2020)

Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
por: Dere, Ruhee, et al.
Publicado: (2010)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis
por: Zhou, Bu-gao, et al.
Publicado: (2017)

TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
por: Chen, Chong, et al.
Publicado: (2008)

Dysregulation of mTOR activity through LKB1 inactivation
por: Zhou, Wei, et al.
Publicado: (2013)

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study
por: Ma, Xueying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c38i7e42gi9vp56nhqohnorabq